Skip to main content
Filing year 2024

HOPE FUNDS FOR CANCER RESEARCH

Newport, Rhode Island·EIN 20-5799367·NTEE H123 · Medical Research·3
Total revenue
$520k
Total assets
$1.1M
Total expenses
$523k
Reported officers
22
Mission

To encourage and finance research of innovative cancer treatment and detection for the most difficult-to-treat and understudied cancers.

Reported officers (all unpaid)

No paid executives reported in 2024. HOPE FUNDS FOR CANCER RESEARCH reported 22 unpaid officers and board members on its 990.

Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Trustee
Financial trend

Revenue and expenses over time

HOPE FUNDS FOR CANCER RESEARCH reported revenue and expenses across 2 filing years.

RevenueExpenses
$752k
$517k
2023
$520k
$523k
2024
Total revenue and total expenses from IRS Form 990 filings.
Sector benchmark

What Medical Research executives earn

HOPE FUNDS FOR CANCER RESEARCH reported no executive compensation in its latest filing. For context, the highest-paid executive at a comparable medical research organization nationwide earns a median of $114,840.

25th percentile
$40k
Median
$114,840
75th percentile
$234k
90th percentile
$424k

These are medical research sector-wide figures, not this organization's reported pay. Based on 283 organizations across 283 filings (2021 – 2023).

See full Medical Research compensation data
Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.